Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 08-Mar-24 4:20 PM View:  | Chacko Jacob President and CEO Director | Oric Pharmaceuticals, Inc. (ORIC) | 06-Mar-24 | Private Sale (Planned) | 40,000 | $16.21 | $648,380.00 | (5%) 768.54K to 728.54K | |
| 08-Feb-24 8:01 PM View: | Chacko Jacob President and CEO Director | Oric Pharmaceuticals, Inc. (ORIC) | 07-Feb-24 | Sale (Planned) | 26,042 | $12.30 | $320,186.00 | (3%) 794.59K to 768.54K | |
| 08-Feb-24 8:01 PM View: | Chacko Jacob President and CEO Director | Oric Pharmaceuticals, Inc. (ORIC) | 06-Feb-24 | Sale (Planned) | 13,958 | $12.12 | $169,160.00 | (2%) 808.54K to 794.59K | |
| 19-Dec-23 7:39 PM View: | Chacko Jacob President and CEO Director | Oric Pharmaceuticals, Inc. (ORIC) | 15-Dec-23 | Option Exercise | 38,667 | -- | -- | 5% 784.42K to 823.08K | |
| 19-Dec-23 7:40 PM View: | Piscitelli Dominic Chief Financial Officer | Oric Pharmaceuticals, Inc. (ORIC) | 15-Dec-23 | Option Exercise | 14,042 | -- | -- | (14%) 103.13K to 89.09K | |
| 19-Dec-23 7:39 PM View: | Chacko Jacob President and CEO Director | Oric Pharmaceuticals, Inc. (ORIC) | 15-Dec-23 | Option Sale | 14,539 | $8.58 | $124,813.00 | (2%) 823.08K to 808.54K | |
| 19-Dec-23 7:40 PM View: | Piscitelli Dominic Chief Financial Officer | Oric Pharmaceuticals, Inc. (ORIC) | 15-Dec-23 | Sale | 5,282 | $8.58 | $45,338.00 | (6%) 89.09K to 83.81K | |
| 19-Dec-23 7:42 PM View: | Multani Pratik S Chief Medical Officer | Oric Pharmaceuticals, Inc. (ORIC) | 15-Dec-23 | Option Exercise | 14,042 | -- | -- | 93% 15.05K to 29.09K | |
| 19-Dec-23 7:42 PM View: | Multani Pratik S Chief Medical Officer | Oric Pharmaceuticals, Inc. (ORIC) | 15-Dec-23 | Option Sale | 5,282 | $8.59 | $45,350.70 | (18%) 29.09K to 23.81K | |
| 11-Jul-23 9:28 PM View: | Chacko Jacob President and CEO Director | Oric Pharmaceuticals, Inc. (ORIC) | 11-Jul-23 | Sale (Planned) | 5,156 | $8.01 | $41,287.20 | (< 1%) 785.81K to 780.65K | |
| 11-Jul-23 9:28 PM View: | Chacko Jacob President and CEO Director | Oric Pharmaceuticals, Inc. (ORIC) | 10-Jul-23 | Sale (Planned) | 10,508 | $8.01 | $84,212.20 | (1%) 796.32K to 785.81K | |
| 07-Jul-23 4:35 PM View: | Chacko Jacob President and CEO Director | Oric Pharmaceuticals, Inc. (ORIC) | 05-Jul-23 | Sale (Planned) | 4,336 | $8.01 | $34,710.60 | (< 1%) 800.65K to 796.32K | |
| 28-Jun-23 7:18 PM View: | Chacko Jacob President and CEO Director | Oric Pharmaceuticals, Inc. (ORIC) | 26-Jun-23 | Sale (Planned) | 20,000 | $8.03 | $160,562.00 | (2%) 820.65K to 800.65K | |
| 16-Dec-22 8:47 PM View: | Chacko Jacob President and CEO Director | Oric Pharmaceuticals, Inc. (ORIC) | 15-Dec-22 | Option Exercise | 16,666 | -- | -- | 2% 806.12K to 822.79K | |
| 16-Dec-22 8:51 PM View: | Multani Pratik S Chief Medical Officer | Oric Pharmaceuticals, Inc. (ORIC) | 15-Dec-22 | Option Sale | 2,089 | $3.25 | $6,789.25 | (22%) 9.51K to 7.42K | |
| 16-Dec-22 8:47 PM View: | Chacko Jacob President and CEO Director | Oric Pharmaceuticals, Inc. (ORIC) | 15-Dec-22 | Option Sale | 5,764 | $3.25 | $18,733.00 | (< 1%) 822.79K to 817.02K | |
| 16-Dec-22 8:49 PM View: | Piscitelli Dominic Chief Financial Officer | Oric Pharmaceuticals, Inc. (ORIC) | 15-Dec-22 | Option Exercise | 6,041 | -- | -- | 10% 63.47K to 69.51K | |
| 16-Dec-22 8:49 PM View: | Piscitelli Dominic Chief Financial Officer | Oric Pharmaceuticals, Inc. (ORIC) | 15-Dec-22 | Option Sale | 2,089 | $3.25 | $6,789.25 | (3%) 69.51K to 67.42K | |
| 16-Dec-22 8:51 PM View: | Multani Pratik S Chief Medical Officer | Oric Pharmaceuticals, Inc. (ORIC) | 15-Dec-22 | Option Exercise | 6,041 | -- | -- | 174% 3.47K to 9.51K | |
| 13-May-22 6:52 PM View: | Chacko Jacob President and CEO Director | Oric Pharmaceuticals, Inc. (ORIC) | 13-May-22 | Purchase | 76,072 | $2.82 | $214,561.00 | 10% 726.58K to 802.65K | |
| 13-May-22 6:52 PM View: | Chacko Jacob President and CEO Director | Oric Pharmaceuticals, Inc. (ORIC) | 12-May-22 | Purchase | 69,354 | $2.75 | $190,467.00 | 11% 657.23K to 726.58K | |
| 13-May-22 6:52 PM View: | Chacko Jacob President and CEO Director | Oric Pharmaceuticals, Inc. (ORIC) | 11-May-22 | Private Purchase | 304,574 | $2.90 | $883,569.00 | 86% 352.65K to 657.23K | |
| 31-Mar-22 8:51 PM View: | Piscitelli Dominic Chief Financial Officer | Oric Pharmaceuticals, Inc. (ORIC) | 31-Mar-22 | Private Purchase | 60,000 | $5.36 | $321,624.00 | 100% 0 to 60.0K | |
| 25-Mar-22 6:42 PM View: | Chacko Jacob President and CEO Director | Oric Pharmaceuticals, Inc. (ORIC) | 25-Mar-22 | Purchase | 50,000 | $4.54 | $227,170.00 | 17% 302.65K to 352.65K | |
| 25-Mar-22 6:42 PM View: | Chacko Jacob President and CEO Director | Oric Pharmaceuticals, Inc. (ORIC) | 24-Mar-22 | Purchase | 42,873 | $5.03 | $215,660.00 | 17% 259.78K to 302.65K | |
| 25-Mar-22 6:42 PM View: | Chacko Jacob President and CEO Director | Oric Pharmaceuticals, Inc. (ORIC) | 23-Mar-22 | Private Purchase | 257,127 | $4.98 | $1,280,880.00 | 9696% 2.65K to 259.78K | |
| 16-Nov-21 4:49 PM View: | Column Group Ii, Lp 10% Owner | Oric Pharmaceuticals, Inc. (ORIC) | 16-Nov-21 | Disposition (other) | 287,702 | -- | -- | (7%) 4.05M to 3.76M | |
| 16-Nov-21 4:49 PM View: | Column Group Ii, Lp 10% Owner | Oric Pharmaceuticals, Inc. (ORIC) | 16-Nov-21 | Acquisition (other) | 461,208 | -- | -- | 10% 4.78M to 5.25M | |
| 16-Nov-21 4:49 PM View: | Column Group Ii, Lp 10% Owner | Oric Pharmaceuticals, Inc. (ORIC) | 16-Nov-21 | Disposition (other) | 1,200,000 | -- | -- | (23%) 5.25M to 4.05M | |
| 16-Nov-21 4:49 PM View: | Column Group Ii, Lp 10% Owner | Oric Pharmaceuticals, Inc. (ORIC) | 12-Nov-21 | Option Exercise | 16,625 | $16.00 | $266,000.00 | < 1% 4.77M to 4.78M | 10% |
| 16-Sep-21 6:19 PM View: | Heyman Richard A. Director | Oric Pharmaceuticals, Inc. (ORIC) | 15-Sep-21 | Market Sale (Planned) | 682 | $25.03 | $17,073.70 | (< 1%) 229.45K to 228.77K | (< 1%) |
| 16-Sep-21 6:17 PM View: | Chacko Jacob President and CEO Director | Oric Pharmaceuticals, Inc. (ORIC) | 15-Sep-21 | Market Sale (Planned) | 3,736 | $25.06 | $93,628.60 | (58%) 6.39K to 2.65K | < 1% |
| 16-Sep-21 6:17 PM View: | Chacko Jacob President and CEO Director | Oric Pharmaceuticals, Inc. (ORIC) | 14-Sep-21 | Market Sale (Planned) | 4,420 | $25.05 | $110,706.00 | (41%) 10.81K to 6.39K | (< 1%) |
| 16-Sep-21 6:19 PM View: | Heyman Richard A. Director | Oric Pharmaceuticals, Inc. (ORIC) | 14-Sep-21 | Market Sale (Planned) | 706 | $25.05 | $17,686.10 | (< 1%) 230.16K to 229.45K | (< 1%) |
| 14-Sep-21 4:01 PM View: | Chacko Jacob President and CEO Director | Oric Pharmaceuticals, Inc. (ORIC) | 13-Sep-21 | Market Sale (Planned) | 2,801 | $25.02 | $70,088.90 | (21%) 13.61K to 10.81K | 3% |
| 14-Sep-21 4:01 PM View: | Chacko Jacob President and CEO Director | Oric Pharmaceuticals, Inc. (ORIC) | 10-Sep-21 | Market Sale (Planned) | 2,942 | $25.08 | $73,783.30 | (18%) 16.55K to 13.61K | 3% |
| 09-Sep-21 10:00 PM View: | Chacko Jacob President and CEO Director | Oric Pharmaceuticals, Inc. (ORIC) | 08-Sep-21 | Market Sale (Planned) | 200 | $25.03 | $5,007.00 | (1%) 16.75K to 16.55K | 6% |
| 09-Sep-21 10:00 PM View: | Chacko Jacob President and CEO Director | Oric Pharmaceuticals, Inc. (ORIC) | 07-Sep-21 | Market Sale (Planned) | 5,981 | $25.11 | $150,173.00 | (26%) 22.73K to 16.75K | 6% |
| 09-Sep-21 4:36 PM View: | Heyman Richard A. Director | Oric Pharmaceuticals, Inc. (ORIC) | 07-Sep-21 | Market Sale (Planned) | 1,086 | $25.11 | $27,272.20 | (< 1%) 232.33K to 231.24K | 6% |
| 28-May-21 7:36 PM View: | Chacko Jacob President and CEO Director | Oric Pharmaceuticals, Inc. (ORIC) | 27-May-21 | Market Sale (Planned) | 400 | $25.07 | $10,028.00 | (2%) 23.13K to 22.73K | 2% |
| 24-May-21 7:30 PM View: | Heyman Richard A. Director | Oric Pharmaceuticals, Inc. (ORIC) | 24-May-21 | Market Sale (Planned) Duplicate | 100 | $25.00 | $2,500.00 | (< 1%) 232.43K to 232.33K | 1% |
| 24-May-21 7:27 PM View: | Chacko Jacob President and CEO Director | Oric Pharmaceuticals, Inc. (ORIC) | 24-May-21 | Market Sale (Planned) | 12 | $25.00 | $300.00 | (< 1%) 23.14K to 23.13K | 1% |
| 24-May-21 7:29 PM View: | Scheller Richard H Director | Oric Pharmaceuticals, Inc. (ORIC) | 24-May-21 | Market Sale (Planned) | 100 | $25.00 | $2,500.00 | (< 1%) 39.19K to 39.09K | 1% |
| 24-May-21 7:27 PM View: | Chacko Jacob President and CEO Director | Oric Pharmaceuticals, Inc. (ORIC) | 21-May-21 | Market Sale (Planned) | 4,790 | $25.20 | $120,688.00 | (17%) 27.93K to 23.14K | 2% |
| 24-May-21 7:29 PM View: | Scheller Richard H Director | Oric Pharmaceuticals, Inc. (ORIC) | 21-May-21 | Market Sale (Planned) | 1,231 | $25.19 | $31,008.30 | (3%) 40.42K to 39.19K | 2% |
| 24-May-21 7:30 PM View: | Heyman Richard A. Director | Oric Pharmaceuticals, Inc. (ORIC) | 21-May-21 | Market Sale (Planned) | 600 | $25.25 | $15,150.00 | (< 1%) 233.03K to 232.43K | 2% |
| 24-May-21 7:30 PM View: | Heyman Richard A. Director | Oric Pharmaceuticals, Inc. (ORIC) | 20-May-21 | Market Sale (Planned) | 700 | $25.08 | $17,558.00 | (< 1%) 233.73K to 233.03K | 2% |
| 24-May-21 7:27 PM View: | Chacko Jacob President and CEO Director | Oric Pharmaceuticals, Inc. (ORIC) | 20-May-21 | Market Sale (Planned) | 2,468 | $25.07 | $61,863.90 | (8%) 30.4K to 27.93K | 2% |
| 24-May-21 7:29 PM View: | Scheller Richard H Director | Oric Pharmaceuticals, Inc. (ORIC) | 20-May-21 | Market Sale (Planned) | 659 | $25.08 | $16,528.00 | (2%) 41.08K to 40.42K | 2% |
| 18-May-21 8:22 PM View: | Heyman Richard A. Director | Oric Pharmaceuticals, Inc. (ORIC) | 18-May-21 | Market Sale (Planned) | 2,161 | $25.32 | $54,715.40 | (< 1%) 235.89K to 233.73K | 3% |
